Authors/Disclosures
|
Puneet K. Gupta, MD
(Neurology Consultants of Dallas, PA)
|
No disclosure on file |
|
Nirav C. Shah, MBBS
(Kane Hall Barry Neurology)
|
No disclosure on file |
|
Olaf Stuve, MD, PhD, FAAN
(UT Southwestern Medical Center)
|
Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA. |
|
Ramon R. Diaz-Arrastia, MD, PhD, FAAN
(University of Pennsylvania)
|
Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense. |
|
Christopher Wallick, PharmD
(Avanir)
|
Dr. Wallick has received personal compensation for serving as an employee of Genentech. Dr. Wallick has stock in Genentech. |
|
Paul C. Van Ness, MD, FAAN
|
No disclosure on file |
|
Mark Agostini, MD
(U.T. Southwestern Medical Center)
|
Dr. Agostini has nothing to disclose. |
|
Harold Koendgen, MD
|
Dr. Koendgen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Koendgen has received stock or an ownership interest from F. Hoffmann-La Roche Ltd . |